Hangzhou Coco Healthcare Products Co.Ltd. Net Assets
Hangzhou Coco Healthcare Products Co.Ltd. net assets. Based on the latest financial reports, Hangzhou Coco Healthcare Products Co.Ltd. (301009) has net assets worth CN¥1.41 Billion CNY (≈ $206.56 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.15 Billion ≈ $314.74 Million USD) and total liabilities (CN¥739.23 Million ≈ $108.17 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Hangzhou Coco Healthcare Products Co.Ltd growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.41 Billion |
| % of Total Assets | 65.63% |
| Annual Growth Rate | 16.92% |
| 5-Year Change | 107.1% |
| 10-Year Change | N/A |
| Growth Volatility | 44.25 |
Net Assets of Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
Net assets of Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024. This chart illustrates how Hangzhou Coco Healthcare Products Co.Ltd.'s net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Hangzhou Coco Healthcare Products Co.Ltd to measure how much of total assets are equity-financed.
Annual Net Assets for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
The table below shows the annual net assets of Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024. For live market cap and overall valuation, see Hangzhou Coco Healthcare Products Co.Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.41 Billion ≈ $206.55 Million |
-2.63% |
| 2023-12-31 | CN¥1.45 Billion ≈ $212.12 Million |
+1.25% |
| 2022-12-31 | CN¥1.43 Billion ≈ $209.51 Million |
-5.00% |
| 2021-12-31 | CN¥1.51 Billion ≈ $220.53 Million |
+121.12% |
| 2020-12-31 | CN¥681.55 Million ≈ $99.73 Million |
+48.79% |
| 2019-12-31 | CN¥458.05 Million ≈ $67.03 Million |
-14.49% |
| 2018-12-31 | CN¥535.64 Million ≈ $78.38 Million |
+13.35% |
| 2017-12-31 | CN¥472.55 Million ≈ $69.15 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Hangzhou Coco Healthcare Products Co.Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 67.5% over the analyzed period, indicating profitable operations and earnings retention.
Hangzhou Coco Healthcare Products Co.Ltd. Net Assets Breakdown (December 2024)
Hangzhou Coco Healthcare Products Co.Ltd. net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥306.85 Million | 23.00% |
| Common Stock | CN¥271.86 Million | 20.38% |
| Other Comprehensive Income | CN¥81.82 Million | 6.13% |
| Other Components | CN¥673.55 Million | 50.49% |
| Total Equity | CN¥1.33 Billion | 100.00% |
Hangzhou Coco Healthcare Products Co.Ltd. Competitors by Market Cap
The table below lists competitors of Hangzhou Coco Healthcare Products Co.Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Digiworld Corp
VN:DGW
|
$322.68 Million |
|
Norske Skog Asa
OL:NSKOG
|
$322.73 Million |
|
Ind-Swift Laboratories Limited
NSE:INDSWFTLAB
|
$322.82 Million |
|
Jiangsu Chunlan Refrigerating Equipment Stock Co Ltd
SHG:600854
|
$323.06 Million |
|
Beijing Sanfo Outdoor Products Co Ltd
SHE:002780
|
$322.55 Million |
|
Vetropack Holding SA
SW:VETN
|
$322.51 Million |
|
ENDOMINES FINLAND OYJ EO1
F:H13
|
$322.39 Million |
|
Vox Royalty Corp.
TO:VOXR
|
$322.24 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hangzhou Coco Healthcare Products Co.Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,372,736,913 to 1,334,074,525, a change of -38,662,388 (-2.8%).
- Net income of 31,172,830 contributed positively to equity growth.
- Dividend payments of 20,138,587 reduced retained earnings.
- Share repurchases of 49,693,884 reduced equity.
- Other comprehensive income increased equity by 4,618,297.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥31.17 Million | +2.34% |
| Dividends Paid | CN¥20.14 Million | -1.51% |
| Share Repurchases | CN¥49.69 Million | -3.72% |
| Other Comprehensive Income | CN¥4.62 Million | +0.35% |
| Other Changes | CN¥-4.62 Million | -0.35% |
| Total Change | CN¥- | -2.82% |
Book Value vs Market Value Analysis
This analysis compares Hangzhou Coco Healthcare Products Co.Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.58x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.75x to 1.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥2.16 | CN¥8.11 | x |
| 2018-12-31 | CN¥2.43 | CN¥8.11 | x |
| 2019-12-31 | CN¥1.47 | CN¥8.11 | x |
| 2020-12-31 | CN¥3.03 | CN¥8.11 | x |
| 2021-12-31 | CN¥5.20 | CN¥8.11 | x |
| 2022-12-31 | CN¥4.98 | CN¥8.11 | x |
| 2023-12-31 | CN¥4.76 | CN¥8.11 | x |
| 2024-12-31 | CN¥5.14 | CN¥8.11 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hangzhou Coco Healthcare Products Co.Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.34%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.89%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.57x
- Recent ROE (2.34%) is below the historical average (10.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 9.71% | 5.32% | 0.82x | 2.22x | CN¥-1.24 Million |
| 2018 | 12.36% | 6.59% | 0.91x | 2.06x | CN¥11.40 Million |
| 2019 | 21.92% | 7.45% | 1.09x | 2.69x | CN¥47.55 Million |
| 2020 | 34.89% | 13.09% | 1.09x | 2.44x | CN¥152.67 Million |
| 2021 | 2.81% | 3.35% | 0.57x | 1.47x | CN¥-101.73 Million |
| 2022 | -3.19% | -3.64% | 0.61x | 1.44x | CN¥-178.38 Million |
| 2023 | 1.47% | 1.87% | 0.54x | 1.45x | CN¥-117.09 Million |
| 2024 | 2.34% | 2.89% | 0.52x | 1.57x | CN¥-102.23 Million |
Industry Comparison
This section compares Hangzhou Coco Healthcare Products Co.Ltd.'s net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,307,015,864
- Average return on equity (ROE) among peers: 6.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hangzhou Coco Healthcare Products Co.Ltd. (301009) | CN¥1.41 Billion | 9.71% | 0.52x | $322.63 Million |
| Lonkey Industrial Co Ltd Guangzhou (000523) | $1.79 Billion | 2.20% | 1.34x | $768.16 Million |
| Tianjin Yiyi Hygiene Products Co Ltd (001206) | $1.77 Billion | 5.83% | 0.12x | $424.51 Million |
| Hunan Resun Co Ltd (001218) | $2.06 Billion | 5.82% | 0.30x | $380.79 Million |
| Qingdao Kingking Applied Chemistry Co Ltd (002094) | $3.39 Billion | 1.43% | 0.64x | $487.30 Million |
| C&S Paper Co Ltd (002511) | $263.02 Million | 15.48% | 3.36x | $1.46 Billion |
| Anhui Deli Household Glass Co Ltd (002571) | $1.47 Billion | -4.17% | 0.37x | $533.97 Million |
| Mingchen Health Co Ltd Class A (002919) | $739.25 Million | 3.43% | 0.68x | $632.06 Million |
| Chongqing Baiya Sanitary Products Co (003006) | $459.92 Million | 14.72% | 0.39x | $1.32 Billion |
| Chengdu Rainbow Appliance Gr (003023) | $568.77 Million | 12.72% | 0.92x | $300.28 Million |
| Fujian Green Pine Co Ltd (300132) | $559.86 Million | 5.12% | 0.91x | $448.26 Million |
About Hangzhou Coco Healthcare Products Co.Ltd.
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as feminine, cleaning, famil… Read more